首页 | 本学科首页   官方微博 | 高级检索  
     

两种不同抗体双弹头标记物导向治疗肝癌的比较
引用本文:宋向群 李志革. 两种不同抗体双弹头标记物导向治疗肝癌的比较[J]. 细胞与分子免疫学杂志, 1998, 14(1): 47-50
作者姓名:宋向群 李志革
作者单位:广西医科大学附属肿瘤医院化疗科
摘    要:在动物实验的基础上,比较了抗AFP单克隆抗体(mAb)和抗AFP多克隆抗体(pAb)两种不同抗体双弹头标记物在肝癌患者体内的生物代谢情况。结果显示,两种抗体标记物的血浆清除半衰期均在24h左右,mAb标记物的清除较pAb标记物略慢。尿清除的半衰期,mAb标记物约为120h,而pAb标记物则约为18h,表明二者的体内生物代谢不同,疗效可能不一。

关 键 词:肝肿瘤  放射免疫治疗  免疫轭合物  生物代谢

A comparison of two kinds of antibodies labeled with dual warheads for radioimmunotherapy in patients with primary liver cancer
SONG Xiang Qun,LI Zhi Ge,WU Ying De et al.. A comparison of two kinds of antibodies labeled with dual warheads for radioimmunotherapy in patients with primary liver cancer[J]. Chinese journal of cellular and molecular immunology, 1998, 14(1): 47-50
Authors:SONG Xiang Qun  LI Zhi Ge  WU Ying De et al.
Abstract:Based on the experimental animals, the in vivo metabolisms of two immunoconjugates, 131 I anti AFP pAb MMC and 131 I anti AFP mAb MMC, which have dual warheads for radioimmunotherapy in patients with primary liver cancer were compared. The results showed that the clearance half lives in plasma were all about 24 hours, with a little longer for 131 I anti AFP mAb MMC. And the half life of excretion of 131 I anti AFP mAb MMC in urine was about 120 h, much longer than that 18 h of 131 I anti AFP pAb MMC. These results suggest that the metabolic mechanisms of the two kinds of labeled agents were different.
Keywords:liver neoplasm radioimmunotherapy immunoconjugate biological metabolism
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号